Predictors of malignancy in pancreatic head mass: A prospective study

Pan African Medical Journal

Volumn 9, Issue , 2011, Pages

  Sivarman, Arjun ^a   Muthukrishnan, Ashok ^a   Senguttvan, Nagendra Boopathy ^b   Suchak, Suraj Anil ^a   Kannan, Umashankkar ^b  

^a KASTURBA MEDICAL COLLEGE   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

CA 19 9 Antigen; Pancreatic Carcinoma

Indexed keywords

BILIRUBIN; CA 19-9 ANTIGEN;

ARTICLE; ASPIRATION CYTOLOGY; BILIRUBIN BLOOD LEVEL; CHRONIC PANCREATITIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INDIA; JAUNDICE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PANCREAS BIOPSY; PANCREAS CARCINOMA; PANCREAS TUMOR; PANCREATIC HEAD MASS; PANCREATICODUODENECTOMY; PREDICTIVE VALUE; PROSPECTIVE STUDY; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; TERTIARY HEALTH CARE; WEIGHT REDUCTION;

EID: 84856324827     PISSN: 19378688     EISSN: None     Source Type: Journal    
DOI: 10.4314/pamj.v9i1.71206     Document Type: Article

References (20)

1. Howe GR. Epidemiology of Cancer of the Pancreas In: Cameron Jl, Ed-Pancreatic Cancer, London 2001; 1-12
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer Statistics, 2007. CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66. This article on PubMed
3. Hawes RH, Xiong Q, Waxman I. A Multispecialty approach to the Diagnosis and Management of Pancreatic Cancer. Am J Gastroenterol. 2000 Jan;95(1):17-31. This article on PubMed
4. Abraham SC, Wilentz RE, Yeo CJ. Pancreaticoduodenectomy (Whipple Resections) in Patients without Malignancy: Are they All "Chronic Pancreatitis"? Am J Surg Pathol. 2003 Jan;27(1):110-20. This article on PubMed
5. Dimagno EP, Reber HA, Tempero MA. AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association. Gastroenterology. 1999 Dec;117(6):1464-84. This article on PubMed
6. Carr JA, Ajlouni M, Wollner I. Adenocarcinoma of The Head of Pancreas: Effects of Surgical and Nonsurgical Therapy on Survival-A Ten-Year Experience. Am Surg. 1999 Dec;65(12):1143-9. This article on PubMed
7. Spencer EA, Appleby PN, Davey GK. Validity of self-reported height and weight in 4808 EPIC-Oxford participants. Public Health Nutrition. 2002; 5:561-565. This article on PubMed
8. Loi S, Milne RL, Friedlander ML. Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1686-91. This article on PubMed
9. Whiteman MK, Hillis SD, Curtis KM. Body mass and mortality after breast cancer diagnosis. Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):2009-14. This article on PubMed
10. Blackburn GL, Bistrian BR, Maini BS. Nutritional and metabolic assessment of the hospitalized patient. JPEN J Parenter Enteral Nutr. 1977;1(1):11-22. This article on PubMed
11. Black WC, Welch HG. Screening for disease. AJR Am J Roentgenol. 1997 Jan;168(1):3-11. This article on PubMed
12. Hong-Ja Kim, Myung-Hwan Kim, Seung-Jae Myung. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve. Am J Gastroenterol. 1999 Jul;94(7):1941-6. This article on PubMed
13. Tessler DA, Catanzaro A, Velanovich V, Havstad S, Goel S. Predictors of cancer in patients with suspected pancreatic malignancy without a tissue diagnosis. Am J Surg. 2006 Feb;191(2):191-7. This article on PubMed
14. Mann DV, Edwards R, Ho S. Elevated Tumor Marker CA19-9: Clinical Interpretation and influence of Obstructive Jaundice. Eur J Surg Oncol. 2000 Aug;26(5):474-9. This article on PubMed
15. Ohshio G, Manabe T, Watanabe Y. Comparative Studies of Du-Pan-2, Carcino Embryonic Antigen and CA19-9 in the Serum and Bile of Patients with Pancreatic and Biliary Tract Diseases: Evaluation of the Influence of Obstructive Jaundice. Am J Gastroenterol. 1990 Oct;85(10):1370-6. This article on PubMed
16. Nuvit Duraker. CEA, CA19-9 and CA125 in Differential Diagnosis of Benign and Malignant Pancreatic Disease with and without Jaundice. Journal of Surgical Oncology. 2007; 95:142-147. This article on PubMed
17. Korkmaz M, Ünal H, Selçuk H. Extraordinarily elevated serum levels of CA 19-9 and rapid decrease after successful therapy: a case report and review of literature. Turk J Gastroenterol. 2010; 21(4):461-3. This article on PubMed
18. Bedi MM, Gandhi MD, Jacob G. CA 19-9 to differentiate benign and malignant masses in chronic pancreatitis: is there any benefit? Indian J Gastroenterol. 2009 Jan-Feb;28(1):24-7. This article on PubMed
19. Cwik G, Wallner G, Skoczylas T, Ciechanski A, Zinkiewicz K. Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. Arch Surg. 2006 Oct;141(10):968-73; discussion 974. This article on PubMed
20. Goonetilleke KS, Siriwardena AK. Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol. 2007 Apr;33(3):266-70. This article on PubMed